Development and implementation of the quality control panel of RT-PCR and real-time RT-PCR for avian influenza A (H5N1) surveillance network in mainland China

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Gao, Rongbao ^a   Gao, Yan ^a   Wen, Leying ^a   Shao, Ming ^b   Zou, Shumei ^a   Li, Changgui ^b   Yang, Lei ^a   Li, Xiyan ^a   Wang, Wei ^a   Shu, Yuelong ^a  

^a NATIONAL INSTITUTE FOR VIRAL DISEASE CONTROL AND PREVENTION   (China)

^b NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

ARTICLE; AVIAN INFLUENZA; CHINA; CONTROLLED STUDY; DISEASE SURVEILLANCE; IN VITRO STUDY; INFLUENZA A (H5N1); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; INTERMETHOD COMPARISON; NONHUMAN; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS; VIRUS DETECTION; EVALUATION; HUMAN; INFLUENZA; ISOLATION AND PURIFICATION; METHODOLOGY; SENTINEL SURVEILLANCE; STANDARD; VIROLOGY;

CHINA; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL SURVEILLANCE; VIROLOGY;

EID: 79952590729     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-67     Document Type: Article

References (25)

1. Curran MD, Ellis JS, Wreghitt TG, Zambon MC. Establishment of a UK National Influenza H5 Laboratory Network. J Med Microbiol 2007, 56(Pt 10):1263-7. 10.1099/jmm.0.47336-0, 17893159.
2. Kimball AM, Moore M, French HM, Arima Y, Ungchusak K, Wibulpolprasert S, Taylor T, Touch S, Leventhal A. Regional infectious disease surveillance networks and their potential to facilitate the implementation of the international health regulation. Med Clin North Am 2008, 92(6):1459-71. xii, 10.1016/j.mcna.2008.06.001, 19061762.
3. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY. Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5: Avian influenza A (H5N1) infection in humans. N Engl J Med 2005, 353(13):1374-85. 10.1056/NEJMra052211, 16192482.
4. Yu H, Gao Z, Feng Z, Shu Y, Xiang N, Zhou L, Huai Y, Feng L, Peng Z, Li Z, Xu C, Li J, Hu C, Li Q, Xu X, Liu X, Liu Z, Xu L, Chen Y, Luo H, Wei L, Zhang X, Xin J, Guo J, Wang Q, Yuan Z, Zhou L, Zhang K, Zhang W, Yang J, Zhong X, Xia S, Li L, Cheng J, Ma E, He P, Lee SS, Wang Y, Uyeki TM, Yang W. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One 2008, 3(8):e2985. 10.1371/journal.pone.0002985, 2515635, 18716658.
5. Chen H, Smith GJ, Zhang SY, Qin K, Wang J, Li KS, Webster RG, Peiris JS, Guan Y. Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 2005, 436(7048):191-2. 10.1038/nature03974, 16007072.
6. Komar N, Olsen B. Avian influenza virus (H5N1) mortality surveillance. Emerg Infect Dis 2008, 14(7):1176-8. 10.3201/eid1407.080161, 2600356, 18598659.
7. China CDC 2009, China CDC., http://www.chinacdc.cn/n272562/n275973/33855.html
8. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K, Cox N. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998, 279(5349):393-6. 10.1126/science.279.5349.393, 9430591.
9. World Health Organization Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to who 2009, World Health Organization., http://www.who.int/csr/disease/avian_influenza/country/cases_table_2009_12_30/en/index.html
10. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman JM, Chunsutthiwat S. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005, 352(4):333-40. 10.1056/NEJMoa044021, 15668219.
11. Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 2006, 368(9554):2211-8. 10.1016/S0140-6736(06)69895-4, 17189032.
12. Sambhara S, Poland GA. H5N1 avian influenza: preventive and therapeutic strategies against pandemic. Annu rev med 2010, 61:187-98. 10.1146/annurev.med.050908.132031, 20059335.
13. Dwyer DE, Smith DW, Catton MG, Barr IG. Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 2006, 185(10 Suppl):S48-53.
14. Fronhoffs S, Totzke G, Stier S, Wernert N, Rothe M, Brüning T, Koch B, Sachinidis A, Vetter H, Ko Y. A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol Cell Probes 2002, 16(2):99-110. 10.1006/mcpr.2002.0405, 12030760.
15. World health organization Recommended laboratory tests to identify avian influenza A virus in specimens from humans World health organization., http://www.who.int/csr/disease/avian_influenza/guidelines/avian_labtests2.pdf
16. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960, 20:37-46.
17. Altman DG. Practical statistics for medical research 1990, London: Chapman and Hall/CRC.
18. Meijer A, Brown C, Hungnes O, Schweiger B, Valette M, van der Werf S, Zambon M. Virology Task Groups of the European Influenza Surveillance Scheme: Programme of the Community Network of Reference Laboratories for Human Influenza to Improve Influenza Surveillance in Europe. Vaccine 2006, 24(44-46):6717-23. 10.1016/j.vaccine.2006.05.068, 16782242.
19. Libeer JC. Role of external quality assurance schemes in assessing and improving quality in medical laboratories. Clin Chim Acta 2001, 309:173-7. 10.1016/S0009-8981(01)00518-6, 11438297.
20. Dequeker E, Ramsden S, Grody WW, Stenzel TT, Barton DE. Quality control in molecular genetic testing. Nat Rev Genet 2001, 2:717-23. 10.1038/35088588, 11533720.
21. Hertzberg M, Neville S, Favaloro E, McDonald D. External quality assurance of DNA testing for thrombophilia mutations. Am J Clin Pathol 2005, 123(2):189-93. 10.1309/09F827BC91M3D91C, 15842041.
22. Hertzberg M, Neville S, McDonald D. External quality assurance of molecular analysis of haemochromatosis gene mutations. J Clin Pathol 2006, 59(7):744-7. 10.1136/jcp.2005.026005, 1860421, 16679356.
23. Ramsden SC, Deans Z, Robinson DO, Mountford R, Sistermans EA, Grody WW, McQuaid S, Patton SJ, Stenhouse SA. Monitoring standards for molecular genetic testing in the United Kingdom, the Netherlands, and Ireland. Genet Test 2006, 10(3):147-56. 10.1089/gte.2006.10.147, 17020464.
24. Losekoot M, Bakker B, Laccone F, Stenhouse S, Elles R. A European pilot quality assessment scheme for molecular diagnosis of Huntington's disease. Eur J Med Genet 1999, 7:217-22.
25. Mueller CR, Kristoffersson U, Stoppa-Lyonnet D. External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years. Ann Oncol 2004, 15(Suppl 1):I14-I17. 10.1093/annonc/mdh652, 15280182.